The Role of Fibrogenesis and Extracellular Matrix Proteins in the Pathogenesis of Graves’ Ophthalmopathy
Open Access
- 14 March 2024
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (6) , 3288
Abstract
Graves’ ophthalmopathy (GO), or thyroid eye disease (TED), is the most frequent extrathyroidal manifestation of Graves’ disease (GD). Inflammation and subsequent aberrant tissue remodeling with fibrosis are important pathogenesis. There are many proposed mechanisms and molecular pathways contributing to tissue remodeling and fibrosis in GO, including adipogenesis, fibroblast proliferation and myofibroblasts differentiation, oxidative stress, endoplasmic reticulum (ER) stress, hyaluronan (HA) and glycosaminoglycans (GAGs) accumulation in the extracellular matrix (ECM) and new concepts of epigenetics modification, such as histone modification, DNA methylation, non-coding RNAs, and gut microbiome. This review summarizes the current understanding of ECM proteins and associated tissue remodeling in the pathogenesis and potential mediators for the treatment of GO.Keywords
Funding Information
- National Taiwan University of Science and Technology (112-2314-B-075-003-MY2, V113C-021)
- Taipei Veterans General Hospital (112-2314-B-075-003-MY2, V113C-021)
This publication has 108 references indexed in Scilit:
- Hearing Dysfunction After Treatment With Teprotumumab for Thyroid Eye DiseaseAmerican Journal of Ophthalmology, 2022
- Challenges and perspectives of selenium supplementation in Graves’ disease and orbitopathyHormones, 2019
- Regression of Ophthalmopathic Exophthalmos in Graves’ Disease After Total Thyroidectomy: a Prospective Study of a Surgical SeriesIndian Journal of Surgery, 2016
- Thyroid surgery for Graves’ disease and Graves’ ophthalmopathyCochrane Database of Systematic Reviews, 2015
- Insulin-like growth factor 1 promotes the proliferation and adipogenesis of orbital adipose-derived stromal cells in thyroid-associated ophthalmopathyExperimental Eye Research, 2013
- Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves’ orbitopathyBest Practice & Research Clinical Endocrinology & Metabolism, 2012
- The role of allopurinol on oxidative stress in experimental hyperthyroidismJournal of Endocrinological Investigation, 2009
- Oxidative Stress Change by Systemic Corticosteroid Treatment Among Patients Having Active Graves OphthalmopathyArchives of Ophthalmology (1950), 2007
- Oxidative stress peripheral parameters in Graves' disease: the effect of methimazole treatment in patients with and without infiltrative ophthalmopathyClinical Biochemistry, 2005
- Superoxide Radical Production Stimulates Retroocular Fibroblast Proliferation in Graves' OphthalmopathyExperimental Eye Research, 1997